CRO Quality Benchmarking  Phase I Service Providers (2014)
Upcoming SlideShare
Loading in...5
×
 

CRO Quality Benchmarking Phase I Service Providers (2014)

on

  • 193 views

In its 6th year, ISR’s “CRO Quality Benchmarking Phase I Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. ...

In its 6th year, ISR’s “CRO Quality Benchmarking Phase I Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 435 service encounters across 28 Phase I CROs, making this report the most comprehensive assessment of Phase I CRO service quality in the industry.

For more details, please visit our website: http://bit.ly/Phase1CRO

Statistics

Views

Total Views
193
Views on SlideShare
189
Embed Views
4

Actions

Likes
0
Downloads
2
Comments
0

1 Embed 4

http://www.slideee.com 4

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

CRO Quality Benchmarking  Phase I Service Providers (2014) CRO Quality Benchmarking Phase I Service Providers (2014) Document Transcript

  • QUALITY CRO BENCHMARKING PHASE I CRO Quality Benchmarking Phase I Service Providers (2014) Info@ISRreports.com ©2014 Industry Standard Research www.ISRreports.com PREVIEW
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 2 act with confidence Report Overview In its 6th year, ISR’s “CRO Quality Benchmarking Phase I Service Providers (2014)” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied satisfaction ratings from 435 service encounters across 28 Phase I CROs, making this report the most comprehensive assessment of Phase I CRO service quality in the industry. 255Charts and Graphs 113Respondents 154Pages 435Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions • Phase I Leaders • Proposal Volume • Service Provider Usage • Service Provider Preference • Service Provider Cost Perceptions 2. Service Provider Selection Drivers • Most Important Service Provider Attributes • Service Provider Attributes Gaining Importance 3. Service Provider Performance and Scorecards Across Attributes • “Staff Characteristics” Ratings • “Operational Excellence” Ratings • “Organizational and Finance” Ratings • Performance Summary by Category • Service Provider Loyalty 4. Service Provider Service Quality Profiles 5. All Study Data How you can use this report: Study Sponsors • Make a more informed purchase of Phase I services by understanding which service providers best fit your company’s needs • Broaden your Phase I CRO evaluation list by accessing peer-based service quality ratings across 28 critical attributes • Pinpoint potential delivery concerns early in a CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps Phase I Service Providers • Uncover your own — and competitor — delivery strengths and weaknesses • Design messaging to tout your company’s strengths • Compete more effectively by understanding buyers’ selection criteria and outsourcing trends NEXT: Companies Included Report Structure:
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 3 act with confidence Service Quality Metrics • Metrics for minimizing change orders • Metrics for staff turnover • Metrics for database lock timelines • Local market / Regulatory knowledge • Detailed plan for timely project communications • Project team chemistry • Metrics for first patient / first visit timelines • Access to a broad range of services • Access to “unique” tests, machines, equipment • Location of Phase I unit(s) within your country • Financial strength / stability • Metrics for site start-up • Technology for real-time access to data • Timely access to open bed / clinic space • Offers innovative solutions • Patient/ volunteer recruitment strategy • Responsiveness • Metrics for data quality • Up-front contingency planning, risk management • Low cost • Location of Phase I unit(s) in different global regions • Metrics for meeting overall project timelines • Scientific knowledge • Project manager quality • Prior positive experience with service provider • Experience of the Phase I unit’s lead investigator • Access to patient populations • Therapeutic expertise CROs Included in this Report • Biotrial • CEDRA • Celerion • Charles River • CHDR • Chiltern • Clinical Research Services (CRS) • Covance • DaVita • DCRI-Duke • Frontage • HungaroTrial • ICON • INC Research • inVentiv Health Clinical • Medpace • PAREXEL • PPD • PRA • Premier Research • Quintiles • Quotient Clinical • Rho • SGS Life Sciences • Siro Clinpharm • Theorem • US Oncology • WCCT Global 7% C-level 15% President/ VP 55% Director 21% Manager 2% Other Participant Job Title Participant Geography Participant Company Size 60% North America 29% Europe Asia/ Other 11% 50% Large Companies (R&D $1B or more) 27% Mid-Size Companies (R&D $100M-$999M) 23% Small Companies (R&D less than $100M) Report Metrics Respondent Demographics (N=148) Participant Experience: Mean = 17 years
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 4 act with confidence Table of Contents For full table of contents and additional sample pages, download the full preview from our website: http://bit.ly/Phase1CRO
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 5 act with confidence act with confidence Introduction www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 7 Introduction Welcome to ISR’s 2014 CRO Quality Benchmarking Phase I Service Providers report� This report marks the sixth edition of this study and, though the study design is revisited and refreshed each year to account for evolution within the industry, the impetus for performing this research remains the same� Over time, Industry Standard Research has accumulated a wealth of knowledge around service quality and CRO performance� Understanding and utilizing this information allows stakeholders within the industry to make informed decisions when choosing a CRO for Phase I services� ISR knows that selecting a CRO isn’t easy� There are a myriad of factors to evaluate for each CRO being considered� Does the provider have the necessary therapeutic expertise? Will the trial be completed on time and within budget? Will the provider have sufficient access to patients? Does the lead investigator have sufficient experience? Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry� In the CRO Quality Benchmarking Phase I report, ISR provides the data necessary to answer these questions – and many more – with confidence� 113 decision-makers have weighed in with their CRO selection criteria and outsourcing behaviors� They have provided feedback on 435 recent service encounters across 28 Phase I CROs� 17 providers have received detailed profiles, eight large, multi-service CROs; six non-large, multi-service CROs; and three Phase I focused CROs� Find out in which areas large CROs dominate and in which performance areas the smaller or more focused CROs shine� Not only does this report enable more educated purchases of CRO services, it also allows Phase I service providers to get a behind-the-scenes look at customers’ perceptions of their performance� Providers can determine areas of strength and understand where they may need to close the gap relative to competitors� As they say, knowledge is power� Having a grasp on customer beliefs, attitudes, and experiences will help CROs effectively promote their strengths and improve areas in which they are falling short� Sample Page
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 6 act with confidence act with confidence Service Provider Performance and Scorecards Across Attributes www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 27 Figure 2 – “Operational Excellence” Ratings Performance in Operational Excellence shows more variability among Phase I providers� The non-large, multi-service providers Quotient Clinical and SGS Life Sciences stand out for going beyond expectations as well as Phase I focused provider Clinical Research Services (CRS)� Respondents also rate PPD as more frequently exceeding expectations in Operational Excellence compared to other large, multi- service providers� Technology for real-time access to data Speed of site start-up Data Quality Local market / regulatory knowledge Meeting Overall Project Timelines Meeting Database Lock Timelines Meeting First Patient / First Visit Timelines Offers Innovative Solutions Patient / Volunteer Recruitment Up-front contingency planning, risk management Timely project communications Covance ICON INC Research inVentiv Health Clinical PAREXEL PPD PRA Quintiles Charles River Medpace Premier Research Quotient Clinical SGS Life Sciences US Oncology Celerion Clinical Research Services (CRS) WCCT Global Operational Excellence LARGE MULTI-SERVICE CROS NON-LARGE MULTI-SERVICE CROS PRIMARILY PHASE I FOCUSED CROS Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency © Industry Standard Research Sample Page Technology for real-time access to data Speed of site start-up Data Quality Local market / regulatory knowledge Meeting Overall Project Timelines Meeting Database Lock Timelines Meeting First Patient / First Visit Timelines Offers Innovative Solutions Patient / Volunteer Recruitment Up-front contingency planning, risk management Timely project communications Company A Company B Company C Company D Company E Company F Company G Company H Company I Company J Company L Company M Company N Company O Company P Company Q Company R Operational Excellence LARGE MULTI-SERVICE CROS NON-LARGE MULTI-SERVICE CROS PRIMARILY PHASE I FOCUSED CROS Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency Figure 2 – “Operational Excellence” Ratings
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 7 act with confidence act with confidence Study Data www.ISRreports.com ©2014 | CRO Quality Benchmarking Phase I Service Providers (2014) 145 Sponsor Preferences Scenario Trade-offs “Would you prefer…?” (Base = 113) CRO QUALITY BENCHMARKING PHASE I 143 25% 75% 20% lower cost of a study Reaching patient recruitment goals 10% faster within the study 76% 24% A CRO offer you recruitment guarantees d them controlling site selection To maintain control over site selection wi recruitment guarantees Sponsor Preferences Scenario Trade-offs “Would you prefer…?” (Base = 113) CRO QUALITY BENCHMARKING PHASE I 143 25% 75% 20% lower cost of a study Reaching patient recruitment goals 10% faster within the study 76% 24% A CRO offer you recruitment guarantees driven by them controlling site selection To maintain control over site selection with no recruitment guarantees Sponsor Preferences Scenario Trade-offs “Would you prefer…?” (Base = 113) © Industry Standard Research © Industry Standard Research Sample Page
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 8 act with confidence Sample PageSample Page For full table of contents and additional sample pages, download the full preview from our website: http://bit.ly/Phase1CRO
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 9 act with confidence Ordering Information Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.    For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports. About Industry Standard Research Save on this, or any ISR report, by registering a free account Register now • Receive a $250 instant credit towards any ISR report • Earn 10% credit towards all future purchases • Receive advanced notifications on ISR’s latest reports and free resources For pricing and ordering information, please visit our website: http://bit.ly/Phase1CRO
  • www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Phase I Service Providers (2014) 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10 act with confidence www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10 act with confidence The ISR Difference Custom-quality syndicated market research www.ISRreports.com ISR's Reports The Common Syndicated Reportvs. How confident are you? vs. DataCollection ISR's proprietary data collection tools and channels support fast, high quality data collection Struggle to recruit the right targets and enough of them vs. SampleSizes Robust sample sizes that instill confidence Often insufficient industry representation that leaves you defending results vs.vs. Research methods Mostly primary research; always appropriate for the topic One size fits all; usually publically available data vs.vs. Respondents Sophisticated screening ensures genuine decision-makers Undisclosed methodologies and respondent demographics vs.vs. Analysts Decades of experience means more insights that are immediately usable Junior analysts capable of reporting numbers